{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:33:04Z","timestamp":1760985184402},"reference-count":59,"publisher":"Informa UK Limited","issue":"11","license":[{"start":{"date-parts":[[2014,11,2]],"date-time":"2014-11-02T00:00:00Z","timestamp":1414886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A glycoconjugate construct was based on attachment of V. cholerae O139 hydrazine-treated lipopolysaccharide (LPS) to carboxylated bovine serum albumin (CBSA) via its amino group. The immunological properties of the glycoconjugate were tested using BALB\/c mice, injected subcutaneously without any adjuvant three times at 2\u2009weeks interval. The immunogenicity of the conjugate was estimated by enzyme-linked immunosorbent assay, testing of anti-LPS IgG, IgM, and IgA antibodies. The conjugate elicited a statistically significant increase of LPS-specific IgG levels in mice (p\u2009&amp;lt;\u20090.001). The specific anti-LPS IgG and IgA response after the second booster dose was significantly higher compared with reference and unconjugated detoxified LPS response. Antibodies elicited by the dLPS\u2013CBSA conjugate were vibriocidal.<\/jats:p>","DOI":"10.1080\/09168451.2014.942251","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T08:45:11Z","timestamp":1406623511000},"page":"1817-1824","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of <i>Vibrio cholerae<\/i> O139"],"prefix":"10.1080","volume":"78","author":[{"given":"Anna","family":"Fleischhackerov\u00e1","sequence":"first","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavol","family":"Farka\u0161","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al\u017ebeta","family":"\u010c\u00ed\u017eov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slavom\u00edr","family":"Bystrick\u00fd","sequence":"additional","affiliation":[{"name":"Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,11,2]]},"reference":[{"key":"2021033107162454600_CIT0001","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","volume":"363","author":"Sack","year":"2004","journal-title":"Lancet"},{"key":"2021033107162454600_CIT0002","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/infdis\/170.3.701","article-title":"The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae","volume":"170","author":"Berche","year":"1994","journal-title":"J. Infect. Dis"},{"key":"2021033107162454600_CIT0003","doi-asserted-by":"publisher","first-page":"11388","DOI":"10.1073\/pnas.91.24.11388","article-title":"The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants","volume":"91","author":"Waldor","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021033107162454600_CIT0004","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1046\/j.1365-2958.1996.407928.x","article-title":"Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1","volume":"19","author":"Comstock","year":"1996","journal-title":"Mol. Microbiol"},{"key":"2021033107162454600_CIT0005","first-page":"77","volume-title":"Vibrio cholerae and cholera","author":"Manning","year":"1993"},{"key":"2021033107162454600_CIT0006","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/mpat.1994.1024","article-title":"Bengal possesses a capsular polysaccharide which may confer increased virulence","volume":"16","author":"Weintraub","year":"1994","journal-title":"Microb. Pathog"},{"key":"2021033107162454600_CIT0007","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/ejb.1995.232.issue-2","article-title":"Structure of capsular polysacharide of Vibrio cholerae O139 synonym Bengal containing D-galactose 4,6-cyclophosphate","volume":"232","author":"Knirel","year":"1995","journal-title":"Eur. J. Biochem"},{"key":"2021033107162454600_CIT0008","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0020-2452(96)85763-0","article-title":"Capsular polysaccharide-protein conjugate vaccines against Vibrio cholerae O139 Bengal","volume":"93","author":"Johnson","year":"1995","journal-title":"B. I. Pasteur"},{"key":"2021033107162454600_CIT0009","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1128\/IAI.64.9.3778-3785.1996","article-title":"Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development","volume":"64","author":"Johnson","year":"1996","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0010","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/0264-410X(96)00035-7","article-title":"Serum antibacterial and antitoxin response in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection","volume":"14","author":"Nandy","year":"1996","journal-title":"Vaccine"},{"key":"2021033107162454600_CIT0011","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/IAI.64.1.343-345.1996","article-title":"Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge","volume":"64","author":"Sengupta","year":"1996","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0012","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/S0264-410X(99)00097-3","article-title":"Antibodies to the truncated (short) form of O polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strain and such protection is mediated by inhibition of intestinal colonization of vibrios","volume":"17","author":"Nandy","year":"1999","journal-title":"Vaccine"},{"key":"2021033107162454600_CIT0013","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(95)90698-3","article-title":"Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype","volume":"345","author":"Coster","year":"1995","journal-title":"Lancet"},{"key":"2021033107162454600_CIT0014","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/infdis\/172.3.883","article-title":"Initial clinical studies of CVC 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge","volume":"172","author":"Tacket","year":"1995","journal-title":"J. Infect. Dis"},{"key":"2021033107162454600_CIT0015","doi-asserted-by":"publisher","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"key":"2021033107162454600_CIT0016","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"key":"2021033107162454600_CIT0017","doi-asserted-by":"publisher","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent, killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS ONE"},{"key":"2021033107162454600_CIT0018","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"2021033107162454600_CIT0019","first-page":"117","article-title":"Cholera vaccines: WHO position paper","volume":"85","author":"WHO","year":"2010","journal-title":"Wkly. Epidemiol. Rec"},{"key":"2021033107162454600_CIT0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","article-title":"Conjugate vaccines","volume":"119","author":"Goldblatt","year":"2000","journal-title":"Clin. Exp. Immunol"},{"key":"2021033107162454600_CIT0021","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1128\/IAI.68.9.5037-5043.2000","article-title":"Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice","volume":"68","author":"Kossaczka","year":"2000","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0022","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1128\/IAI.69.5.3488-3493.2001","article-title":"Preparation immunogenicity and protective efficacy in a murine model of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid","volume":"69","author":"Boutonnier","year":"2001","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0023","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1128\/IAI.00398-10","article-title":"Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by anti-lipopolysaccharide antibodies that inhibit bacterial motility","volume":"78","author":"Bishop","year":"2010","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0024","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/1875035401104010018","article-title":"Is a universal, one dose cholera vaccine possible?","volume":"4","author":"Wade","year":"2011","journal-title":"Open Vaccine J"},{"key":"2021033107162454600_CIT0025","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/IAI.60.8.3201-3208.1992","article-title":"Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin","volume":"60","author":"Gupta","year":"1992","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0026","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/IAI.66.7.3095-3099.1998","article-title":"Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers","volume":"66","author":"Gupta","year":"1998","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0027","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10719-008-9160-6","article-title":"Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba","volume":"26","author":"Grandjean","year":"2009","journal-title":"Glycoconjugate J"},{"key":"2021033107162454600_CIT0028","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1099\/jmm.0.020875-0","article-title":"Immunological efficacy of glycoconjugates derived from Vibrio cholerae O1 serotype Ogawa detoxified LPS in mice","volume":"59","author":"Paulovicova","year":"2010","journal-title":"J. Med. Microbiol"},{"key":"2021033107162454600_CIT0029","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/2049-632X.12022","article-title":"Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies","volume":"67","author":"Grandjean","year":"2013","journal-title":"Pathog. Dis"},{"key":"2021033107162454600_CIT0030","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Anal. Biochem"},{"key":"2021033107162454600_CIT0031","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1021\/ac010313s","article-title":"Direct microextraction and analysis of rough-type lipopolysaccharides by combined thin-layer chromatography and MALDI mass spectrometry","volume":"73","author":"Therisod","year":"2001","journal-title":"Anal. Chem"},{"key":"2021033107162454600_CIT0032","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/rcm.5084","article-title":"A new rapid and micro-scale hydrolysis, using triethylamine citrate, for lipopolysaccharide characterization by mass spectrometry","volume":"25","author":"Chafchaouni-Moussaoui","year":"2011","journal-title":"Rapid Commun. Mass. Sp"},{"key":"2021033107162454600_CIT0033","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ijbiomac.2013.06.014","article-title":"Comparison of EDC and DMTMM efficiency in glycoconjugate preparation","volume":"60","author":"Farka\u0161","year":"2013","journal-title":"Int. J. Biol. Macromol"},{"key":"2021033107162454600_CIT0034","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jpba.2007.06.007","article-title":"Evaluation of different mannan polysaccharide usage in enzyme-linked immunosorbent assay for specific antibodies determination","volume":"45","author":"Libjakov\u00e1","year":"2007","journal-title":"J. Pharm. Biomed. Anal"},{"key":"2021033107162454600_CIT0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/CDLI.2.6.685-688.1995","article-title":"Comparison of the vibrocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1","volume":"2","author":"Quadri","year":"1995","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"2021033107162454600_CIT0036","first-page":"83","volume-title":"Methods in carbohydrates chemistry","author":"Westphal","year":"1965"},{"key":"2021033107162454600_CIT0037","doi-asserted-by":"publisher","first-page":"5990","DOI":"10.1128\/IAI.70.11.5990-5996.2002","article-title":"Role of Vibrio cholerae O139 surface polysaccharides in intestinal colonization","volume":"70","author":"Nesper","year":"2002","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0038","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0008-6215(96)00135-8","article-title":"Structural analysis of the lipopolysaccharide from Vibrio cholerae O139","volume":"290","author":"Cox","year":"1996","journal-title":"Carbohydr. Res"},{"key":"2021033107162454600_CIT0039","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0008-6215(96)00131-0","article-title":"Structural analysis of the O-antigen core region of the lipopolysaccharide from Vibrio cholerae O139","volume":"290","author":"Cox","year":"1996","journal-title":"Carbohydr. Res"},{"key":"2021033107162454600_CIT0040","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/ejb.1997.247.issue-1","article-title":"Structural studies on the short-chain lipopolysaccharide of Vibrio cholerae O139 Bengal","volume":"247","author":"Knirel","year":"1997","journal-title":"Eur. J. Biochem"},{"key":"2021033107162454600_CIT0041","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1128\/JCM.40.7.2635-2637.2002","article-title":"Escalating association of Vibrio cholerae O139 with cholera outbreaks in India","volume":"40","author":"Sinha","year":"2002","journal-title":"J. Clin. Microbiol"},{"key":"2021033107162454600_CIT0042","doi-asserted-by":"publisher","first-page":"e38633","DOI":"10.1371\/journal.pone.0038633","article-title":"Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS ONE"},{"key":"2021033107162454600_CIT0043","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3201\/eid1910.130626","article-title":"Vibrio cholerae O1 El Tor and O139 Bengal Strains Carrying ctxBET, Bangladesh","volume":"19","author":"Rashed","year":"2013","journal-title":"Emerg. Infect. Dis"},{"key":"2021033107162454600_CIT0044","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1757-4749-6-3","article-title":"Genome sequence and comparative analysis of a\u00a0Vibrio cholerae O139 strain E306 isolated from a\u00a0cholera case in China","volume":"6","author":"Yi","year":"2014","journal-title":"Gut Pathog"},{"key":"2021033107162454600_CIT0045","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1286-4579(03)00035-2","article-title":"Vibrio cholerae O139 Bengal: odysey of a fortuitous variant","volume":"5","author":"Ramamurthy","year":"2003","journal-title":"Microb. Infect"},{"key":"2021033107162454600_CIT0046","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.carres.2005.07.017","article-title":"Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa","volume":"340","author":"Saksena","year":"2005","journal-title":"Carbohydr. Res"},{"key":"2021033107162454600_CIT0047","first-page":"291","volume-title":"The polysaccharide","author":"Bishop","year":"1982"},{"key":"2021033107162454600_CIT0048","first-page":"11","article-title":"Immunologic considerations for the development of conjugate vaccines","volume":"10","author":"Garner","year":"1989","journal-title":"Contrib. Microbiol. Immunol"},{"key":"2021033107162454600_CIT0049","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/339583","article-title":"Induction of protective imunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a\u00a0protein","volume":"185","author":"Chernyak","year":"2001","journal-title":"J. Infect. Dis"},{"key":"2021033107162454600_CIT0050","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000231427","article-title":"Experimental Studies on Cholera Immunization","volume":"49","author":"Svennerholm","year":"1975","journal-title":"Int. Arch. Allergy Appl. Immunol"},{"key":"2021033107162454600_CIT0051","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/IAI.13.3.735-740.1976","article-title":"Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin\/toxoid","volume":"13","author":"Svennerholm","year":"1976","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0052","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/IAI.59.3.977-982.1991","article-title":"New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection","volume":"59","author":"Winner","year":"1991","journal-title":"Infect. Immun"},{"key":"2021033107162454600_CIT0053","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/CDLI.6.6.812-818.1999","article-title":"Lipopolysaccharide- and Cholera Toxin-Specific Subclass Distribution of B-Cell Responses in Cholera","volume":"6","author":"Qadri","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"2021033107162454600_CIT0054","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1371\/journal.pntd.0000221","article-title":"Susceptibility to Vibrio cholerae infection in a\u00a0cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"Harris","year":"2008","journal-title":"PLoS Neglect. Trop. D"},{"key":"2021033107162454600_CIT0055","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002030050651","article-title":"Morphological and physical characterization of the capsular layer of Vibrio cholerae O139","volume":"170","author":"Meno","year":"1998","journal-title":"Arch. Microbiol"},{"key":"2021033107162454600_CIT0056","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.vaccine.2008.11.101","article-title":"Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide","volume":"27","author":"Attridge","year":"2009","journal-title":"Vaccine"},{"key":"2021033107162454600_CIT0057","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CDLI.7.3.444-450.2000","article-title":"Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis","volume":"7","author":"Attridge","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"2021033107162454600_CIT0058","first-page":"383","article-title":"Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139","volume":"9","author":"Attridge","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol"},{"key":"2021033107162454600_CIT0059","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/infdis\/121.5.505","article-title":"The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement","volume":"121","author":"Neoh","year":"1970","journal-title":"J. Infect. Dis"}],"container-title":["Bioscience, Biotechnology, and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bbb\/article-pdf\/78\/11\/1817\/36798223\/bbb1817.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bbb\/article-pdf\/78\/11\/1817\/36798223\/bbb1817.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:47:07Z","timestamp":1654602427000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bbb\/article\/78\/11\/1817\/5938301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,2]]},"references-count":59,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,2]]},"published-print":{"date-parts":[[2014,11,2]]}},"URL":"https:\/\/doi.org\/10.1080\/09168451.2014.942251","relation":{},"ISSN":["0916-8451","1347-6947"],"issn-type":[{"value":"0916-8451","type":"print"},{"value":"1347-6947","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11,2]]},"published":{"date-parts":[[2014,11,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbbb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tbbb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}